Regulation of energy metabolism and mitochondrial function in skeletal muscle during lipid overfeeding in healthy men

J Clin Endocrinol Metab. 2014 Jul;99(7):E1254-62. doi: 10.1210/jc.2013-4379. Epub 2014 Mar 31.

Abstract

Context/objective: The aim of this study was to evaluate the regulation of the fuel partitioning and energy metabolism in skeletal muscle during lipid overfeeding in healthy men. Design/Participants/Intervention: Thirty-nine healthy volunteers were overfed for 56 days with a high-fat diet (3180 kJ/d). Energy metabolism (indirect calorimetry) was characterized in the fasting state and during a test meal before and at the end of the diet. Skeletal muscle biopsies were taken at day 0 and day 56.

Main outcome measures: Change in gene expression, mitochondrial respiration, nicotinamide adenine dinucleotide (NAD(+)) content, and acetylation of peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) in skeletal muscle was measured.

Results: Overfeeding increased body weight (+2.6 kg) and fat mass concomitantly with a shift in the use of substrates as energy fuel toward preferential oxidation of carbohydrates instead of lipids. Changes in lipid metabolic gene expression supported this observation, with a reduction in pyruvate dehydrogenase kinase 4 expression that could be the consequences of decreased NAD(+) concentration and reduced deacetylase activity of the sirtuins, as supported by hyperacetylation of PGC-1α after overfeeding. Interestingly, this reduction of the sirtuin PGC-1α pathway was associated with increased mitochondrial gene expression and higher respiration rate under these conditions.

Conclusion: Adaptation to lipid overfeeding and regulation of fuel partitioning in human muscle appear to rely on a dissociation between the regulatory functions of the sirtuin-PGC-1α pathway on fatty acid oxidation and on mitochondrial regulation. This may facilitate lipid storage during a period of positive energy balance while maintaining mitochondrial functions and oxidative capacities.

Trial registration: ClinicalTrials.gov NCT00905892.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cell Respiration / drug effects
  • Cell Respiration / genetics
  • Diet, High-Fat
  • Dietary Fats / administration & dosage*
  • Energy Metabolism* / drug effects
  • Energy Metabolism* / genetics
  • Humans
  • Lipid Metabolism / drug effects
  • Lipid Metabolism / genetics
  • Male
  • Mitochondria, Muscle / drug effects
  • Mitochondria, Muscle / physiology*
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / metabolism*
  • Overnutrition / genetics
  • Overnutrition / metabolism*
  • Oxidation-Reduction

Substances

  • Dietary Fats

Associated data

  • ClinicalTrials.gov/NCT00905892